A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum

Kazumi Matsushima-Nagata1, Hiroyuki Sugiuchi1, Kensaku Anraku1

  • 1Kumamoto Health Science University, Kumamoto, Japan.

Analytical Biochemistry
|November 15, 2020
PubMed

Insights

A new assay simplifies measuring high-density lipoprotein cholesterol (HDL-C) subclasses (HDL2-C and HDL3-C). This method offers accurate, convenient, and low-cost routine diagnosis of HDL-C subclasses in serum.

Area of Science:

  • Clinical Chemistry
  • Biochemistry
  • Lipid Metabolism

Background:

  • Accurate measurement of high-density lipoprotein cholesterol (HDL-C) subclasses, specifically HDL2-C and HDL3-C, is crucial for cardiovascular risk assessment.
  • Existing methods for determining HDL-C subclasses are often complex, labor-intensive, and require specialized expertise, limiting their routine clinical application.

Purpose of the Study:

  • To develop a convenient, homogeneous, and accurate assay for quantifying HDL-C subclasses (HDL2-C and HDL3-C) in serum.
  • To establish a cost-effective method for routine clinical diagnosis of HDL-C subclasses using standard automated analyzers.

Main Methods:

  • Investigated cholesterol reactivities of lipoprotein fractions (HDL2, HDL3, LDL, VLDL) using polyethylene glycol (PEG)-modified enzymes.
  • Optimized concentrations of dextran sulfate and magnesium nitrate to achieve selective reaction with HDL3-C.
  • Utilized dynamic light scattering to measure particle size changes in lipoprotein fractions.
  • Validated the assay against ultracentrifugation in serum samples from healthy volunteers and type 2 diabetes patients.

Main Results:

  • Optimized concentrations of dextran sulfate and magnesium nitrate induced selective reactivity for HDL3-C by altering particle sizes of other lipoproteins (HDL2, LDL, VLDL) while maintaining HDL3 particle size.
  • The developed assay demonstrated good correlation with ultracentrifugation for determining HDL-C subclasses.
  • The assay allows for accurate measurement without the need for sample preprocessing.

Conclusions:

  • A novel, convenient, and homogeneous assay for determining HDL-C subclasses (HDL2-C and HDL3-C) has been developed.
  • This assay can be readily implemented on general automatic analyzers, enabling low-cost routine diagnosis.
  • The method provides a valuable tool for assessing cardiovascular risk through precise HDL-C subclass quantification.